{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:58:50Z","timestamp":1761947930477},"reference-count":109,"publisher":"Elsevier BV","issue":"52","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.vaccine.2013.10.050","type":"journal-article","created":{"date-parts":[[2013,10,24]],"date-time":"2013-10-24T16:46:04Z","timestamp":1382633164000},"page":"6201-6209","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["How many published cases of serious adverse events after yellow fever vaccination meet Brighton Collaboration diagnostic criteria?"],"prefix":"10.1016","volume":"31","author":[{"given":"Roger E.","family":"Thomas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Spragins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane L.","family":"Lorenzetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.10.050_bib0005","series-title":"Vaccines","article-title":"Yellow fever vaccine","author":"Monath","year":"2013"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0010","unstructured":"WHO. Yellow fever reported cases. http:\/\/apps.who.int\/immunization_monitoring\/en\/globalsummary\/timeseries\/tsincidenceyfe.htm [accessed 09.08.12]."},{"key":"10.1016\/j.vaccine.2013.10.050_bib0015","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S1473-3099(11)70147-5","article-title":"The revised global yellow fever risk map and recommendations for vaccination 2010 consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever","volume":"11","author":"Jentes","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0020","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s11908-012-0256-6","article-title":"Mapping the risk of yellow fever infection","volume":"14","author":"Hill","year":"2012","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0025","doi-asserted-by":"crossref","first-page":"B61","DOI":"10.1016\/j.vaccine.2012.11.035","article-title":"The estimated mortality impact of vaccinations forecast to be administered during 2011\u20132020 in 73 countries supported by the GAVI Alliance","volume":"31S","author":"Lee","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0030","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1086\/340104","article-title":"Prevention of yellow fever in persons traveling to the tropics","volume":"34","author":"Monath","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0035","series-title":"World Health Organization Regional Office for the Western Pacific Region. Immunization safety surveillance: guidelines for immunization programme managers on surveillance of adverse events following immunization","year":"2013"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0040","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/j.vaccine.2008.11.035","article-title":"Guidelines for collection, analysis and presentation of vaccine safety data in surveillance systems","volume":"27","author":"Bonhoeffer","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0045","doi-asserted-by":"crossref","first-page":"5675","DOI":"10.1016\/j.vaccine.2007.02.064","article-title":"Anaphylaxis: case definition and guidelines for data collection, analysis, and presentation of immunization safety data","volume":"25","author":"R\u0171ggeberg","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0050","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1016\/j.vaccine.2010.04.041","article-title":"Can the Brighton Collaboration case definitions be used to improve the quality of Adverse Event Following Immunization (AEFI) reporting? Anaphylaxis as a case study","volume":"28","author":"Gold","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0055","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.1016\/j.vaccine.2007.04.060","article-title":"Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"25","author":"Sejvar","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0060","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.vaccine.2010.06.003","article-title":"Guillain\u2013Barr\u00e9 syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data","volume":"29","author":"Sejvar","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0065","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1016\/j.vaccine.2012.04.067","article-title":"Viscerotropic disease: case definition and guidelines for collection, analysis, and presentation of immunization safety data","volume":"30","author":"Gershman","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0070","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1016\/j.vaccine.2009.07.082","article-title":"Viscerotropic disease following yellow fever vaccination in Peru","volume":"27","author":"Whittembury","year":"2009","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2013.10.050_bib0075","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"The PRISMA group preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.vaccine.2013.10.050_bib0080","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/157488611797579258","article-title":"Reporting rates of yellow fever vaccine 17D or 17DD-associated serious adverse events in pharmacovigilance data bases: systematic review","volume":"6","author":"Thomas","year":"2011","journal-title":"Curr Drug Saf"},{"issue":"28","key":"10.1016\/j.vaccine.2013.10.050_bib0085","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1016\/j.vaccine.2011.04.055","article-title":"Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: systematic review","volume":"29","author":"Thomas","year":"2011","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2013.10.050_bib0090","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4269\/ajtmh.2012.11-0525","article-title":"The safety of yellow fever vaccine 17D or 17DD in children, pregnant women HIV+ individuals, and older persons: systematic review","volume":"86","author":"Thomas","year":"2012","journal-title":"J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0095","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0091-6749(99)70245-9","article-title":"Anaphylaxis from yellow fever vaccine","volume":"103","author":"Kelso","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0100","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1016\/j.vaccine.2008.09.009","article-title":"Adverse event reports following yellow fever vaccination","volume":"26","author":"Lindsey","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0105","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.vaccine.2013.01.054","article-title":"Adverse events following yellow fever preventive vaccination campaigns in eight African countries from 2007 to 2010","volume":"31","author":"Breugelmans","year":"2013","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2013.10.050_bib0110","first-page":"154","article-title":"Vaccination anti amarile compliqu\u00e9e d\u2019une primo infection grave par le virus de l\u2019immunodeficience humaine (VIH 1): \u00e0 propos d\u2019une observation","volume":"2","author":"Fournier","year":"1989","journal-title":"R\u00e9trovirus la Revue du Sida"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0115","article-title":"Clinical and immunological insights on severe adverse neurotropic\/viscerotropic disease following 17D yellow fever vaccination","author":"Silva","year":"2009","journal-title":"Clin Vaccine Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2013.10.050_bib0120","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1001\/jama.1966.03110190153047","volume":"198","year":"1966","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.vaccine.2013.10.050_bib0125","first-page":"30","article-title":"Transmission of yellow fever vaccine virus through breast-feeding \u2013 Brazil, 2009","volume":"59","author":"Couto","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2013.10.050_bib0130","first-page":"65","article-title":"Meningo-encefalite post vacina\u00e7\u00e3o contra a febre amarilla","volume":"18","author":"de","year":"1955","journal-title":"Rev Port Pediatr Pueric"},{"issue":"7","key":"10.1016\/j.vaccine.2013.10.050_bib0135","first-page":"547","article-title":"Un cas d\u2019encephalite apr\u00e8s vaccination anti-amarile par la souche 17 D","volume":"XXXVI","author":"Louis","year":"1981","journal-title":"P\u00e9diatrie"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0140","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0163-4453(90)90807-K","article-title":"Encephalitis in a 13 year-old boy following 17D yellow fever vaccine","volume":"21","author":"Schoub","year":"1990","journal-title":"J Infect"},{"issue":"4892","key":"10.1016\/j.vaccine.2013.10.050_bib0145","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1136\/bmj.2.4892.852","article-title":"Encephalitis in an infant after vaccination with 17 D yellow fever virus","volume":"2","author":"Smith","year":"1954","journal-title":"Br Med J"},{"issue":"4932","key":"10.1016\/j.vaccine.2013.10.050_bib0150","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1136\/bmj.2.4932.182","article-title":"Encephalitis in infants following vaccination with 17 D yellow fever virus: report of a further case","volume":"2","author":"Thomson","year":"1955","journal-title":"Br Med J"},{"issue":"4","key":"10.1016\/j.vaccine.2013.10.050_bib0155","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0248-8663(05)82493-2","article-title":"M\u00e9ningo-enc\u00e9phalite apr\u00e8s vaccination anti-amarile par la souche 17 D: deux observations","volume":"14","author":"Drouet","year":"1993","journal-title":"Rev Med Interne"},{"issue":"6","key":"10.1016\/j.vaccine.2013.10.050_bib0160","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4269\/ajtmh.2009.09-0295","article-title":"Short report: incidence of yellow fever vaccine-associated neurotropic disease","volume":"81","author":"Guimard","year":"2009","journal-title":"Am J Trop Med"},{"issue":"1","key":"10.1016\/j.vaccine.2013.10.050_bib0165","first-page":"131","article-title":"Fatal myeloencephalitis following yellow fever vaccination in a case with HIV infection","volume":"85","author":"Kengsakul","year":"2002","journal-title":"J Med Assoc Thailand"},{"issue":"44","key":"10.1016\/j.vaccine.2013.10.050_bib0170","first-page":"989","article-title":"Adverse events associated with 17D-derived yellow fever vaccination \u2013 United States, 2001\u20132002","volume":"51","author":"Levy","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0175","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.vaccine.2006.11.027","article-title":"Neurologic disease associated with 17D-204 yellow fever vaccination: a report of 15 cases","volume":"25","author":"McMahon","year":"2007","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2013.10.050_bib0180","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0264-410X(93)90329-V","article-title":"Possible association of encephalitis and 17D yellow fever vaccination in a 29-year-old traveller","volume":"11","author":"Merlo","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0185","series-title":"Federation of European Pharmacological Societies EPHAR Congress, Abstract 7P071","first-page":"23","article-title":"Acute transverse myelitis (ATM) following yellow fever vaccination","author":"Mounier","year":"2001"},{"issue":"2","key":"10.1016\/j.vaccine.2013.10.050_bib0190","first-page":"117","article-title":"Encephalitis in man following vaccination with 17D yellow fever virus","volume":"36","author":"Fox","year":"1942","journal-title":"Am J Hyg"},{"issue":"3","key":"10.1016\/j.vaccine.2013.10.050_bib0195","first-page":"477","article-title":"\u00c0 propos de quelques cas de r\u00e9actions nerveuses tardives observ\u00e9es chez des nourissons apr\u00e8s vaccination antiamarile","volume":"49","author":"Panthier","year":"1956","journal-title":"Bull Soc Pathol Exot"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0200","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/13550280903062805","article-title":"Longitudinal myelitis associated with yellow fever vaccination","volume":"15","author":"Chaves","year":"2009","journal-title":"J Neurovirol"},{"issue":"3-A","key":"10.1016\/j.vaccine.2013.10.050_bib0205","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1590\/S0004-282X2009000400029","article-title":"Acute disseminated encephalomyelitis following yellow fever vaccination","volume":"67","author":"Miravalle","year":"2009","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0210","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1529-8027.2002.02010.x","article-title":"Postvaccinal inflammatory neuropathy: peripheral nerve biopsy in 3 cases","volume":"7","author":"Vital","year":"2002","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0215","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1055\/s-2001-18392","article-title":"Optikusneuritis nach Impfung gegen Hepatitis A, B und Gelbfieber mit irreversiblem Visusverlust","volume":"218","author":"Voigt","year":"2001","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0220","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1542\/peds.25.6.956","article-title":"Encephalitis after yellow fever vaccination","volume":"25","author":"Feitel","year":"1960","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0225","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1016\/j.vaccine.2004.01.026","article-title":"Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX","volume":"22","author":"Kitchener","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0230","series-title":"Yellow fever vaccination (World Health Organization monograph series no. 30)","first-page":"143","article-title":"Reactions following vaccination against yellow fever","author":"Stuart","year":"1956"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0235","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1086\/587844","article-title":"Immune response during adverse events after 17D-derived yellow fever vaccination in Europe","volume":"197","author":"Bae","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0240","doi-asserted-by":"crossref","first-page":"8480","DOI":"10.1016\/j.vaccine.2007.08.061","article-title":"Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease","volume":"25","author":"Belsher","year":"2007","journal-title":"Vaccine"},{"issue":"9276","key":"10.1016\/j.vaccine.2013.10.050_bib0245","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(01)05341-7","article-title":"Hepatitis and death following vaccination with 17D-204 yellow fever vaccine","volume":"358","author":"Chan","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.vaccine.2013.10.050_bib0250","doi-asserted-by":"crossref","first-page":"740","DOI":"10.4269\/ajtmh.2010.09-0570","article-title":"Case report: a case of yellow fever vaccine-associated viscerotropic disease in Ecuador","volume":"82","author":"Douce","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0255","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","article-title":"Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases","volume":"358","author":"Martin","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0260","series-title":"Vaccines","article-title":"Yellow fever vaccine","author":"Monath","year":"2008"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0265","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1708-8305.2008.00209.x","article-title":"Yellow fever-associated viscerotropic disease in Barcelona, Spain","volume":"15","author":"Mu\u00f1oz","year":"2008","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0270","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1017\/S0950268804002602","article-title":"Risk of fatal adverse events associated with 17DD yellow fever vaccine","volume":"132","author":"Struchiner","year":"2004","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0275","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(01)05326-0","article-title":"Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases","volume":"358","author":"Vasconcelos","year":"2001","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.vaccine.2013.10.050_bib0280","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/01.SMJ.0000157537.11806.DC","article-title":"Rare case of fatal yellow fever vaccine-associated viscerotropic disease","volume":"98","author":"Gerasimon","year":"2005","journal-title":"South Med J"},{"issue":"12 Suppl.","key":"10.1016\/j.vaccine.2013.10.050_bib0285","first-page":"A286","article-title":"Yellow fever vaccine associated viscerotropic disease in a young woman: a rare complication of a common vaccine","volume":"35","author":"Kennedy","year":"2007","journal-title":"Crit Care Med"},{"issue":"5","key":"10.1016\/j.vaccine.2013.10.050_bib0290","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4269\/ajtmh.2010.10-0001","article-title":"Short report: suspected yellow fever vaccine-associated viscerotropic adverse events (1973 and 1978), United States","volume":"82","author":"Monath","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0295","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1086\/590187","article-title":"Case of yellow fever vaccine-associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES","volume":"198","author":"Pulendran","year":"2008","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2013.10.050_bib0300","doi-asserted-by":"crossref","first-page":"333","DOI":"10.4269\/ajtmh.2006.75.333","article-title":"Yellow fever vaccine-associated viscerotropic disease (YEL-AVD) and corticosteriod therapy: eleven United States cases, 1996\u20132004","volume":"75","author":"Vellozzi","year":"2006","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0305","first-page":"51","article-title":"Um caso de hepatite letal ap\u00f3s vacina\u00e7\u00e3o anti-amar\u00edlica","volume":"129","author":"de Mello Vieira","year":"1965","journal-title":"J Soc Cienc Med Lisb"},{"issue":"13","key":"10.1016\/j.vaccine.2013.10.050_bib0310","first-page":"936","article-title":"Adverse effects of attenuated yellow fever vaccine with multiple organ injury \u2013 a case report","volume":"85","author":"Zhou","year":"2005","journal-title":"Zhong Hua Yi Xue Za Zhi"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0315","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1016\/j.vaccine.2006.01.009","article-title":"Characterization of a viscerotropic yellow fever variant from a patient in Brazil","volume":"24","author":"Engel","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0320","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.vaccine.2003.11.002","article-title":"Isolation and characterization of wild type yellow fever virus in cases temporally associated with 17 DD vaccination during an outbreak of yellow fever in Brazil","volume":"22","author":"de Filippis","year":"2004","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2013.10.050_bib0325","first-page":"411","article-title":"Urticarial and erythema multiforme-like eruptions following injections of yellow fever vaccine","volume":"40","author":"Sulzberger","year":"1942","journal-title":"U S Nav Med Bull"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2013.10.050_bib0330","first-page":"4","article-title":"Allergische Reaktion nach Gelbfieberimpfung","volume":"8","author":"Becker","year":"1957","journal-title":"Z Tropenmed Parasitol"},{"issue":"1","key":"10.1016\/j.vaccine.2013.10.050_bib0335","first-page":"23","article-title":"Vaccin antiamarile 17D et allergie","volume":"50","author":"Panthier","year":"1957","journal-title":"Bull Soc Pathol Exot"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0340","first-page":"382","article-title":"Skin reaction to yellow fever vaccine","volume":"2","author":"Truitt","year":"1945","journal-title":"Air Surg Bull"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0345","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.provac.2010.07.012","article-title":"Yellow fever post-marketing surveillance in Brazil","volume":"2","author":"Martins","year":"2010","journal-title":"Proc Vaccinol"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0350","doi-asserted-by":"crossref","DOI":"10.1111\/jtm.12070","article-title":"Safety of the yellow fever vaccine: a retrospective study","author":"Nordin","year":"2013","journal-title":"J Travel Med"},{"issue":"4907","key":"10.1016\/j.vaccine.2013.10.050_bib0355","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/bmj.1.4907.226-b","article-title":"Encephalitis after yellow fever vaccination","volume":"1","author":"Beet","year":"1955","journal-title":"Br Med J"},{"issue":"2","key":"10.1016\/j.vaccine.2013.10.050_bib0360","first-page":"583","article-title":"Thrombotic thrombocytopenic purpura (Moschowitz Syndrome) and death following yellow fever vaccination","volume":"451","author":"Fior","year":"2007","journal-title":"Virchows Archiv"},{"issue":"4894","key":"10.1016\/j.vaccine.2013.10.050_bib0365","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1136\/bmj.2.4894.992-b","article-title":"Encephalitis after yellow fever vaccination","volume":"2","author":"Haas","year":"1954","journal-title":"Br Med J"},{"issue":"4","key":"10.1016\/j.vaccine.2013.10.050_bib0370","doi-asserted-by":"crossref","first-page":"E243","DOI":"10.1503\/cmaj.100619","article-title":"Case report: probable transmission of vaccine strain of yellow fever virus to an infant via breast milk","volume":"183","author":"Kuhn","year":"2011","journal-title":"Can Med Assoc J"},{"issue":"32","key":"10.1016\/j.vaccine.2013.10.050_bib0375","first-page":"1493","article-title":"R\u00e9action m\u00e9ning\u00e9e immune-allergique apr\u00e8s une vaccination anti-amarile","volume":"23","author":"Lachgar","year":"1994","journal-title":"La Presse M\u00e9dicale"},{"issue":"6","key":"10.1016\/j.vaccine.2013.10.050_bib0380","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/0091-6749(83)90438-4","article-title":"The safety of egg-containing vaccines for egg-allergic patients","volume":"71","author":"Miller","year":"1983","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0385","series-title":"Abstracts of the 6th annual meeting of the French pharmacological society: joint meeting with the pharmacological societies of Brazil and Portugal","first-page":"416","article-title":"Safety of travelers\u2019 vaccines: a case of rhabdomyolysis","author":"Nguyen","year":"2002"},{"issue":"4896","key":"10.1016\/j.vaccine.2013.10.050_bib0390","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1136\/bmj.2.4896.1108-a","article-title":"Encephalitis after yellow fever vaccination","volume":"2","author":"Scott","year":"1954","journal-title":"Br Med J"},{"issue":"4940","key":"10.1016\/j.vaccine.2013.10.050_bib0395","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/bmj.2.4940.677-b","article-title":"Encephalitis after yellow fever vaccination","volume":"2","author":"Swift","year":"1955","journal-title":"Br Med J"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0400","series-title":"14th international congress on infectious disease (ICID)","first-page":"629","article-title":"Yellow fever vaccine (YFV) and evetns supposedly attributable to vaccination or immunization (ESAVIs): Argentina's experience","author":"Vizzotti","year":"2010"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0405","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(01)06917-3","article-title":"Letter to the editor","volume":"358","author":"Werfel","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0410","unstructured":"Minist\u00e9rio do Sa\u00fade, Brasil. Boletim de Atualiza\u00e7\u00e3o \u2013 Dezembro\/2009. Emerg\u00eancias em Sa\u00fade P\u00fablica de Import\u00e2ncia Nacional (ESPIN) de Febre Amarela Silvestre em S\u00e3o Paulo e no Rio Grande do Sul e a Situa\u00e7\u00e3o Epidemi\u00f3logica Atual no Brasil (2008\/2009). http:\/\/portal.saude.gov.br [accessed 08.07.13]."},{"key":"10.1016\/j.vaccine.2013.10.050_bib0415","unstructured":"Minist\u00e9ro da Sa\u00fade, Brasil. Subs\u00eddios para discuss\u00e3o e redefini\u00e7\u00e3o da estrat\u00e9gia de vacina\u00e7\u00e3o contra febre amarela no Brasil. 30\u201331\/07\/2009. Minist\u00e9ro da Sa\u00fade, Brasil, 2009. http:\/\/portal.saude.gov.br [accessed 08.07.13]."},{"key":"10.1016\/j.vaccine.2013.10.050_bib0420","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1016\/j.vaccine.2007.01.078","article-title":"Neurological adverse events temporarily associated to mass vaccination against yellow fever in Juiz de Fora Brazil, 1999\u20132005","volume":"25","author":"Fernandes","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0425","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1016\/j.vaccine.2005.01.089","article-title":"Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events","volume":"23","author":"Khromava","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0430","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1016\/j.vaccine.2010.04.002","article-title":"Surveillance for adverse events following immunization (AEFI) in Switzerland-1991\u20132001","volume":"28","author":"Schumacher","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0435","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0140-6736(01)06914-8","article-title":"Effects of yellow fever vaccination","volume":"358","author":"Adhiyaman","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0440","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00296-008-0647-z","article-title":"Vascular involvement of the central nervous system and systemic diseases: etiologies and MRI findings","volume":"28","author":"Appenzeller","year":"2008","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.vaccine.2013.10.050_bib0445","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7205\/MILMED-D-11-00304","article-title":"Yellow fever vaccine-associated viscerotropic disease","volume":"177","author":"Rowland","year":"2012","journal-title":"Mil Med"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0450","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/S0140-6736(01)06916-1","article-title":"Letter to the editor","volume":"358","author":"Troillet","year":"2001","journal-title":"Lancet"},{"issue":"5 Suppl. 1","key":"10.1016\/j.vaccine.2013.10.050_bib0455","first-page":"383","article-title":"Third case of fatal yellow fever vaccine-associated viscerotropic disease in a young Peruvian woman","volume":"87","author":"Turpo","year":"2010","journal-title":"Am Soc Trop Med Hyg"},{"issue":"6286","key":"10.1016\/j.vaccine.2013.10.050_bib0460","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(00)42331-7","article-title":"Acute necrosis of the liver. An unusual case","volume":"243","author":"Van Langenberg","year":"1944","journal-title":"Lancet"},{"issue":"29","key":"10.1016\/j.vaccine.2013.10.050_bib0465","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1016\/j.vaccine.2011.07.044","article-title":"Overview of the clinical consult case review of adverse events following immunization: Clinical Immunization Safety Assessment (CISA) network 2004\u20132009","author":"Williams","year":"2011","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2013.10.050_bib0470","first-page":"307","article-title":"Surveillance of adverse events following immunisation: Australia, 2000\u20132002","volume":"27","author":"Lawrence","year":"2003","journal-title":"Commun Dis Intell"},{"issue":"2","key":"10.1016\/j.vaccine.2013.10.050_bib0475","first-page":"244","article-title":"Age-related risk of adverse events following yellow fever vaccination in Australia","volume":"28","author":"Lawrence","year":"2004","journal-title":"Commun Dis Intell"},{"issue":"5","key":"10.1016\/j.vaccine.2013.10.050_bib0480","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4161\/hv.1.5.2221","article-title":"Yellow fever 17D vaccine safety and immunogenicity in the elderly","volume":"1","author":"Monath","year":"2005","journal-title":"Hum Vaccin"},{"issue":"3","key":"10.1016\/j.vaccine.2013.10.050_bib0485","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.2105\/AJPH.2012.301158","article-title":"Mortality and morbidity among military personnel and civilians during the 1930s and World War II from transmission of hepatitis during yellow fever vaccination: systematic review","volume":"103","author":"Thomas","year":"2013","journal-title":"Am J Pub Health"},{"issue":"2","key":"10.1016\/j.vaccine.2013.10.050_bib0490","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4161\/hv.22714","article-title":"Active assessment of adverse events following yellow fever vaccination of persons aged 60 years or more","volume":"9","author":"Miyaji","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"10","key":"10.1016\/j.vaccine.2013.10.050_bib0495","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.3201\/eid1710.101789","article-title":"Yellow fever virus vaccine-associated deaths in young women","volume":"17","author":"Seligman","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2013.10.050_bib0500","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/INF.0b013e3181bbc571","article-title":"Letter to the editor. Yellow fever vaccination and Kawasaki disease","volume":"28","author":"Schm\u00f6eller","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2013.10.050_bib0505","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1708-8305.2006.00098.x","article-title":"Herpes Zoster after yellow fever vaccination","volume":"14","author":"Bayas","year":"2007","journal-title":"J Travel Med"},{"issue":"10","key":"10.1016\/j.vaccine.2013.10.050_bib0510","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1001\/archneurol.2011.131","article-title":"Yellow fever vaccination and increased relapse rate in travelers with multiple sclerosis","volume":"68","author":"Farez","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0515","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1016\/j.vaccine.2004.01.009","article-title":"Methodological issues arising from systematic reviews of the evidence of safety of vaccines","volume":"22","author":"Price","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0520","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1473-3099(04)00927-2","article-title":"Adverse events after immunisation with aluminium-containing DTP vaccines: systematic review of the evidence","volume":"4","author":"Jefferson","year":"2004","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2013.10.050_bib0525","first-page":"401","article-title":"A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States","volume":"27","author":"Geier","year":"2006","journal-title":"Neuro Endocrinol Lett"},{"issue":"1","key":"10.1016\/j.vaccine.2013.10.050_bib0530","first-page":"75","article-title":"The reaction to yellow fever vaccine (17D), particularly in allergic individuals","volume":"5","author":"Kouwenaar","year":"1953","journal-title":"Documenta de Medicina Geographica et Tropica"},{"issue":"1","key":"10.1016\/j.vaccine.2013.10.050_bib0535","first-page":"71","article-title":"Egg allergy. Significance in typhus and yellow fever vaccination","volume":"45","author":"Sprague","year":"1945","journal-title":"Naval Med Bull"},{"key":"10.1016\/j.vaccine.2013.10.050_bib0540","first-page":"1663","article-title":"Systemic allergic reaction induced by yellow fever vaccine","volume":"43","author":"Swartz","year":"1943","journal-title":"J Lab Clin Med"},{"issue":"6","key":"10.1016\/j.vaccine.2013.10.050_bib0545","doi-asserted-by":"crossref","first-page":"945","DOI":"10.3201\/eid0706.010605","article-title":"Advanced age a risk factor for illness temporally associated with yellow fever vaccination","volume":"7","author":"Martin","year":"2001","journal-title":"Emerg Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1301428X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1301428X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,10]],"date-time":"2022-03-10T13:56:14Z","timestamp":1646920574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1301428X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":109,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0264410X1301428X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.10.050","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How many published cases of serious adverse events after yellow fever vaccination meet Brighton Collaboration diagnostic criteria?","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.10.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}